Amyloid Heart Disease

• DOI: 10.15420/usc.2018.5.1
• Publication Date: 2018-12-17T13:36:20Z
• Authors: Yaser Nemshah; ; ; Alex Clavijo; ; Gyanendra Sharma
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

Cardiac amyloidosis is a group of disorders that develop secondary to the deposition of misfolded proteins in the heart. It can occur in isolation or as part of a systemic disease and can be inherited or acquired. Amyloid light chain (AL) and amyloid transthyretin (ATTR) are the two main forms of amyloid proteins that can infiltrate the heart. With the increased use of advanced imaging techniques and protocols, the recognition and diagnosis of cardiac amyloidosis, especially ATTR, has become easier. New therapies intended to improve survival and quality of life in patients with cardiac amyloidosis are emerging. This article provides an up-to-date review of cardiac amyloidosis.